Friday, November 13, 2026

Robinhood's Numbers Show Why Agentic Finance Is Attracting Money, and Where a Lender-Side Investor Draws the Line

Robinhood's filed results show revenue of $4.473B and net income of $1.883B in FY 2025, against a $541M loss in FY 2023. Around that business, money is moving into AI-agent identity and consolidation deals. We checked the figures against SEC filings and flag where the sources disagree.

LM Salvado
LM Salvado

November 4, 2026

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
Robinhood's Numbers Show Why Agentic Finance Is Attracting Money, and Where a Lender-Side Investor Draws the Line
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Robinhood Markets reported revenue of $4.473 billion for fiscal 2025, up from $1.865 billion in fiscal 2023.1 Over the same two years net income swung from a loss of $541 million to a profit of $1.883 billion, and earnings per share went from -$0.61 to $2.05.1 Those are SEC-filing figures that Via News has checked against the source. They explain why the company sits at the centre of a wider story: fintech is reorganising around AI agents, and capital is following.

One caveat on scale. The dossier holds no outside yardstick, such as a market-wide total or an index weighting. We therefore compare Robinhood only with itself. Revenue is now more than double what it was in 2023. We cannot tell you whether you own it through an index fund, because the material does not say.

The balance sheet behind the product push

Robinhood's cash did not grow in a straight line. It was $4.835 billion at the end of fiscal 2023, $4.332 billion at the end of 2024 and $4.261 billion at the end of 2025.2 That fell even as profits rose. The quarterly figures show a recovery since: $5.012 billion in Q1 2026 (against $4.416 billion a year earlier) and $5.362 billion in Q2 2026 (against $4.162 billion).2

Operating cash flow, the cash the business actually generated from running itself, was uneven. It was $1.181 billion in 2023, then negative $157 million in 2024, then $1.638 billion in 2025.3 A profitable year can still be a cash-negative one, which is a reason to read the cash-flow line and not only the headline profit. Research and development spending stayed in a narrow band: $349 million, $323 million and $355 million over the three years.3 Revenue rose far faster than that spending.

Where reporting diverges. Two records give Robinhood's cash for 30 September 2025 as 4.331 billion and 4.3 billion dollars. The difference is about $31 million, and it comes from rounding. We use the filing-based $4.331 billion.2

Retail trading products: zero fees, for now

Cboe announced at Robinhood's third annual HOOD Summit in Houston that it plans to launch binary contracts tied to company-specific key performance indicators. The products cover 23 companies, are expected in October 2026 and are subject to regulatory approval. Robinhood will be the first retail broker to offer them.4 Cboe will charge no fees on the contracts through the end of 2026, subject to regulatory review, and Robinhood will also offer them fee-free until year-end.5 Cboe's Steve Quirk said: “Earnings contracts give retail investors another tool to inform their strategies and offer an even more precise way to trade on anticipated company KPIs.”4

For an ordinary investor the practical point is that the fee waiver is time-limited and still under regulatory review. A product that is free until a stated date has not shown yet what it earns once fees start. Robinhood also announced other products at the same event, including Robinhood Agent, perpetuals, 24/7 trading and 10X crypto leverage.5 The dossier does not say how any of them performed.

The money going into agent identity

Baselayer, a San Francisco startup that helps financial institutions verify businesses and assess fraud risk, raised $35 million in a Series A led by M13. Picus Capital, Torch Capital, Afore Capital and Matt Thompson of Socure also took part.5,6 It launched an Agentic Identity Suite alongside the round, extending its identity network from businesses to the AI agents that transact for them.5

CEO Jonathan Awad frames the problem as trust: “Agents spin up and they spin down. How can you trust this random one-task agent?”6 His warning is blunt: “agents will just get blocked everywhere” unless they can show they act for legitimate people or businesses.6 The financial case is in the sales cycle. Awad said relationships with financial institutions typically take 12 to 18 months to establish, and large merchant partnerships up to 24 months.6 He also said: “We've essentially streamlined 10 years' worth of selling into two years.”6 This is the company's own claim and we have not verified it independently.

Incumbents buy

On 22 October 2026 LSEG agreed to acquire Octus, a provider of credit intelligence, data and workflows. The cash consideration goes to funds advised by Permira and to Octus management, including founder Kent Collier.5 The dossier does not give a price. The same narrative cites Circle–Tazapay, Grab–Atome and Adobe–Rilo, but the dossier holds no terms or primary documents for them, so we do not analyse them. Via News's reading of the pattern is that established players are buying data and workflow assets rather than building them. That is our interpretation of the narrative, not a stated fact.

The sceptic's view

Norwest partner Sean Jacobsohn is cautious about handing finance to AI: “You don't want AI doing calculations because it is not good at math. There are certain workflows it can handle where it doesn't produce precise numbers. But when you need precision, accuracy and calculations, you can't rely on AI for that.”7 He sees the opening in software, not in core systems. “I think it would be very hard to disrupt the core products of Workday, ADP, SAP, UKG and Dayforce. But it's easier to disrupt some of their secondary products, where the category isn't their core business.”7 On ERP he said there is “a potential opportunity to disrupt NetSuite and Sage,” with disruption coming “more downmarket first.”7 His reasoning on CFO tools: “There's actually one less layer of approval when they're buying their own software, so it is a little easier to replace it when they're the direct buyer.”7

He also tests founders on selling: “Before I invest, I'll go on a lot of sales calls I set up with the CEO to see how good they are at selling. To me, that's a big way of assessing the potential of a company.”7

How much to trust the sources

The measured reliability of our sources differs. The Cboe and Robinhood press release came from a feed where 53% of 6,376 checked claims held up.4 The Crunchbase News articles come from a feed where 49% of 41 checked claims held up.6,7 Neither is high. Treat the quotes above as what the speakers said, not as established fact. Treat Robinhood's SEC figures as the firm ground.

What to watch

  • Whether the Cboe KPI contracts launch in October as planned, and what happens when the fee waiver ends after 2026.
  • Whether Robinhood's operating cash flow stays positive after its swing to negative $157 million in 2024, and whether the Q2 2026 cash of $5.362 billion holds.
  • Whether Baselayer's 12-to-24-month sales cycle shortens as agent identity becomes standard.
  • Whether Jacobsohn's caution proves right: that the first disruption comes in secondary software and downmarket ERP, not in core systems.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· September 30, 2026
    Cboe and Robinhood Announce Planned Launch of New KPI Contracts, Further Expanding Prediction Market Offerings
  2. [2]News articleCrunchbase News
    Exclusive: Can You Trust That AI Agent? Baselayer Raises $35M To Help Companies Decide
  3. [3]News articleCrunchbase News
    Exclusive: Fintech Offers Startups Alternative To Venture Debt With A New Model To Finance Customer Acquisition Costs
  4. [4]News articleCB Insights
    Executive Interview: Arya.ag
  5. [5]News articleCrunchbase News
    The Sales Test This Norwest Partner Gives Founders Before He’ll Invest
  6. [6]News articleCB Insights
    14 repeat founders building agentic commerce
  7. [7]Press releaseGlobeNewswire· July 29, 2026
    1st Quarter Results
  8. [8]News articleCB Insights
    CEO Interview: Ethic
  9. [9]News articleCB Insights
    CEO Interview: Kilde
  10. [10]Press releaseGlobeNewswire· July 3, 2026
    CONVENING NOTICE TO THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
  11. [11]News articleCNBC· September 30, 2026
    Kalshi, Polymarket trading volumes on some products raises questions amid massive growth
  12. [12]News articleYahoo Finance· October 22, 2026
    LSEG to Acquire Octus, Creating Market Leader Across Public and Private Credit Solutions

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com